{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:34Z","timestamp":1772165674373,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10099-4","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T04:47:32Z","timestamp":1731300452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SARS-CoV-2 seroprevalence and associated factors\u00a0among\u00a0outpatient attendees at\u00a0health facilities in different provinces in Chad"],"prefix":"10.1186","volume":"24","author":[{"given":"Koutaya","family":"Dezoumbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumaima","family":"Djarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrillene Laure Deutou","family":"Wondeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Abdelrazak","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Atturo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Na\u00efbe\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck J. D.","family":"Mennechet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdoulaye","family":"Boukar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choroma Ahmat","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issa","family":"Mahamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nontegyol","family":"Armand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahamat Idriss","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Netalar","family":"Honorine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayanlengar","family":"Frederic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam Adami","family":"Moustapha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanda Mberkissam","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam Moussa","family":"Alim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahamat","family":"Grene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noubaramadji Yamti","family":"Suitombaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amine","family":"Akouya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouchemi","family":"Choua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hota","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djallaye","family":"Djimto\u00efbaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Colizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takoudjou Dzomo Guy","family":"Rodrigue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahamat Fayiz","family":"Abakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Mahamat","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"issue":"20","key":"10099_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12916-022-02367-4","volume":"2","author":"G Bwire","year":"2022","unstructured":"Bwire G, Ario AR, Eyu P, Ocom F, Wamala JF, Kusi KA, et al. The COVID-19 pandemic in the African continent. BMC Med. 2022;2(20):167. https:\/\/doi.org\/10.1186\/s12916-022-02367-4.","journal-title":"BMC Med"},{"key":"10099_CR2","unstructured":"World Health Organization. COVID-19 Epidemiological Update. https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c."},{"issue":"2","key":"10099_CR3","doi-asserted-by":"publisher","first-page":"e2271","DOI":"10.1002\/rmv.2271","volume":"32","author":"MRO Chisale","year":"2022","unstructured":"Chisale MRO, Ramazanu S, Mwale SE, Kumwenda P, Chipeta M, Kaminga AC, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: a systematic review and meta-analysis. Rev Med Virol. 2022;32(2):e2271. https:\/\/doi.org\/10.1002\/rmv.2271.","journal-title":"Rev Med Virol"},{"key":"10099_CR4","unstructured":"World Health Organization. COVID-19 Epidemiological Update, 2020. https:\/\/www.who.int\/emergencies\/diseases\/novelcoronavirus-2019\/technical-guidance\/early-investigations."},{"key":"10099_CR5","unstructured":"NOVEMBRE 2020, N\u00b0002 Bulletin d\u2019informations Semestriel du Bureau pays de l\u2019OMS au Tchad. https:\/\/www.afro.who.int\/sites\/default\/files\/2020-12\/Bulletin%20fini%20OMS%20A4.pdf."},{"issue":"11","key":"10099_CR6","doi-asserted-by":"publisher","first-page":"e1004107","DOI":"10.1371\/journal.pmed.1004107","volume":"19","author":"I Bergeri","year":"2022","unstructured":"Bergeri I, Whelan MG, Ware H, Subissi L, Nardone A, Lewis HC, et al. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies. PLoS Med. 2022;19(11):e1004107. https:\/\/doi.org\/10.1371\/journal.pmed.1004107.","journal-title":"PLoS Med"},{"issue":"5","key":"10099_CR7","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.4269\/ajtmh.21-0081","volume":"104","author":"JM Milleliri","year":"2021","unstructured":"Milleliri JM, Coulibaly D, Nyobe B, Rey JL, Lamontagne F, Hocqueloux L, et al. SARS-CoV-2 infection in Ivory Coast: a serosurveillance survey among gold mine workers. Am J Trop Med Hyg. 2021;104(5):1709\u201312. https:\/\/doi.org\/10.4269\/ajtmh.21-0081.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10099_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/jmv.27588","volume":"94","author":"Y Araf","year":"2022","unstructured":"Araf Y, Akter F, Tang YD, Fatemi R, Parvez MSA, Zheng C, et al. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol. 2022;94(5):1825\u201332. https:\/\/doi.org\/10.1002\/jmv.27588.","journal-title":"J Med Virol"},{"key":"10099_CR9","unstructured":"United Nations (2020b) World population prospects-population division-United Nations. https:\/\/population.un.org\/wpp\/."},{"key":"10099_CR10","unstructured":"Worldometer. Chad Population (2019) - Worldometers. https:\/\/www.worldometers.info\/world-population\/chad-population\/."},{"key":"10099_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","volume":"396","author":"M Poll\u00e1n","year":"2020","unstructured":"Poll\u00e1n M, P\u00e9rez-G\u00f3mez B, Pastor-Barriuso R, Oteo J, Hern\u00e1n MA, P\u00e9rez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396:535\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(20)31483-5.","journal-title":"Lancet"},{"key":"10099_CR12","doi-asserted-by":"publisher","DOI":"10.4081\/jphia.2022.2255","author":"ALD Wondeu","year":"2023","unstructured":"Wondeu ALD, Abdelrazakh F, Abakar MF, et al. High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad. J Public Health Afr. 2023. https:\/\/doi.org\/10.4081\/jphia.2022.2255. Epub ahead of print.","journal-title":"J Public Health Afr"},{"issue":"1","key":"10099_CR13","doi-asserted-by":"publisher","first-page":"e1154","DOI":"10.1002\/iid3.1154","volume":"12","author":"ALD Wondeu","year":"2024","unstructured":"Wondeu ALD, Abakar MF, Frasca F, Nodjikouambaye AZ, Abdelrazakh F, Naibei N, et al. Presence of neutralizing SARS-CoV-2 antibodies in asymptomatic population of N\u2019Djamena, Chad. Immun Inflamm Dis. 2024;12(1):e1154. https:\/\/doi.org\/10.1002\/iid3.1154.","journal-title":"Immun Inflamm Dis"},{"key":"10099_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10900-021-00963-8","volume":"46","author":"GR Takoudjou Dzomo","year":"2021","unstructured":"Takoudjou Dzomo GR, Bernales M, L\u00f3pez R, Djofang Kamga Y, Kila Roskem JP, Deassal Mondjimbaye F, et al. Knowledge, attitudes and practices regarding COVID-19 in N\u2019Djamena, Chad. J Community Health. 2021;46:259. https:\/\/doi.org\/10.1007\/s10900-021-00963-8.","journal-title":"J Community Health"},{"key":"10099_CR15","unstructured":"INSEED-TCHAD - POPULATION."},{"key":"10099_CR16","unstructured":"Chad Coronavirus COVID-19 Cases. Tradingeconomics.com. https:\/\/tradingeconomics.com\/chad\/coronavirus-cases."},{"issue":"4","key":"10099_CR17","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/S1473-3099(20)30631-9","volume":"21","author":"RK Arora","year":"2021","unstructured":"Arora RK, Joseph A, Van Wyk J, Rocco S, Atmaja A, May E, et al. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard. Lancet Infect Dis. 2021;21(4):e75\u20136. https:\/\/doi.org\/10.1016\/S1473-3099(20)30631-9. [PubMed: 32763195].","journal-title":"Lancet Infect Dis"},{"key":"10099_CR18","unstructured":"World Health Organization. Over two-thirds of Africans exposed to virus which causes Covid-19: WHO study. WHO Regional Office for Africa. 2022.\u00a0https:\/\/www.afro.who.int\/news\/over-two-thirds-africans-exposed-virus-which-causes-covid-19-who-study."},{"key":"10099_CR19","unstructured":"Institut National De Recherche Biomedicale, department d\u2019epidemiologie moleculaire, Laboratoire de G\u00e9nomique des Pathog\u00e8nes -Rapport Annuel 2021http:\/\/inrb.cd\/images\/2023\/RAPPORT_PAT_GEN_LAB_FR.pdf."},{"key":"10099_CR20","unstructured":"Renforcement des capacit\u00e9s de surveillance g\u00e9nomique au Tchad: l\u2019OMS remet un laboratoire de s\u00e9quen\u00e7age au Ministre de la sant\u00e9 Publique et de la Solidarit\u00e9 nationale. OMS | Bureau r\u00e9gional pour l\u2019Afrique. 2022. https:\/\/www.afro.who.int\/fr\/countries\/chad\/news\/renforcement-des-capacites-de-surveillance-genomique-au-tchad-loms-remet-un-laboratoire-de."},{"issue":"1","key":"10099_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jiph.2022.11.024","volume":"16","author":"K Dhama","year":"2023","unstructured":"Dhama K, Nainu F, Frediansyah A, Yatoo MI, Mohapatra RK, Chakraborty S, et al. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health. 2023;16(1):4. https:\/\/doi.org\/10.1016\/j.jiph.2022.11.024.","journal-title":"J Infect Public Health"},{"issue":"4","key":"10099_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13267","volume":"18","author":"K Sachathep","year":"2024","unstructured":"Sachathep K, Duong YT, Reid G, Dokubo EK, Shang JD, Ndongmo CB, et al. Seroprevalence of SARS-CoV-2 in 10 Regional Capitals of Cameroon, October\u2013December 2020. Influenza Other Respir Viruses. 2024;18(4): e13267. https:\/\/doi.org\/10.1111\/irv.13267.","journal-title":"Influenza Other Respir Viruses"},{"key":"10099_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","volume":"396","author":"S Stringhini","year":"2020","unstructured":"Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396:313\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(20)31304-0.","journal-title":"Lancet"},{"issue":"6","key":"10099_CR24","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.4110\/in.2019.19.e37","volume":"19","author":"SJ Oh","year":"2019","unstructured":"Oh SJ, Lee JK, Shin OS. Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity. Immune Netw. 2019;19(6):e37. https:\/\/doi.org\/10.4110\/in.2019.19.e37.","journal-title":"Immune Netw"},{"key":"10099_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105658","volume":"169","author":"E Pereira","year":"2022","unstructured":"Pereira E, Felipe S, de Freitas R, Ara\u00fajo V, Soares P, Ribeiro J, et al. ABO blood group and link to COVID-19: a comprehensive review of the reported associations and their possible underlying mechanisms. Microb Pathog. 2022;169: 105658. https:\/\/doi.org\/10.1016\/j.micpath.2022.105658.","journal-title":"Microb Pathog"},{"issue":"1","key":"10099_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjh.16797","volume":"190","author":"J Li","year":"2020","unstructured":"Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol. 2020;190(1):24\u20137. https:\/\/doi.org\/10.1111\/bjh.16797.","journal-title":"Br J Haematol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10099-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:01:43Z","timestamp":1731445303000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10099-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10099"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10099-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3942571\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Chad National Bioethics Committee (CNBT) on 08 April 2022 under number: 011CMT\/PC\/PMT\/MESRI\/SG\/CNBT\/2022 and authorized by the Chad Ministry of Public Health under number: N\u00b02326\/CMT\/PC\/PMT\/MSPSN\/SE\/SG\/DGPC\/DPERO\/SRO\/2022. The protocol was presented to 11 focal points including 10 provinces and N\u2019Djamena selected for the study. Training sessions on the data collection tool were organized before the start of data and sample collection. An information sheet was given to each voluntary participant as well as the signature of informed consent and assent for minors. The informed consent was obtained from all participants involved. For adult participants (aged\u2009\u2265\u200916\u00a0years), informed consent was obtained directly from each individual. For minor participants (aged\u2009<\u200916\u00a0years), informed consent was obtained from parents or the legally authorized representative (LAR). In both cases, consent was obtained in accordance with the ethical guidelines established by the approving ethics committee. Each participant was assigned a unique code, and the data was handled confidentially.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1271"}}